<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03723720</url>
  </required_header>
  <id_info>
    <org_study_id>MAP</org_study_id>
    <nct_id>NCT03723720</nct_id>
  </id_info>
  <brief_title>Calculating of Correlations Between ADR, PDR, MAP</brief_title>
  <official_title>Calculating of Correlations Between ADR, PDR, MAP</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Frydek-Mistek</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Frydek-Mistek</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of our study is to compare MAP (mean adenoma per colonoscopy) with ADR (adenoma
      detection rate) and PDR (polyp detection rate) of all colonoscopists in our department
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      ADR (adenoma detection rate) is generally accepted quality indicator. For possible gaming
      with ADR other indicators are needed. MAP (mean adenoma per colonoscopy) reflects the quality
      of examination of entire colon and is considered to be the most objective quality indicator.
      The aim of our study is to compare MAP with ADR and PDR (polyp detection rate) of all
      colonoscopists in our department.

      We want to retrospectively assess the quality indicators of all colonoscopies from January
      2013 to December 2017. We want to calculate ADR, PDR and MAP of all our endoscopists for all
      colonoscopies in patients over 50 years of age excluding therapeutic, IBD, management of
      complications and sigmoidoscopies (screening, surveillance, diagnostic) and separately only
      for screening colonoscopies. Correlations between MAP/ADR and MAP/PDR will be performed using
      Pearson´s correlation coefficient.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 2013</start_date>
  <completion_date type="Actual">December 2017</completion_date>
  <primary_completion_date type="Actual">December 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>correlation between MAP and ADR for all and screening colonoscopies</measure>
    <time_frame>january 2013 - december 2017</time_frame>
    <description>Pearson´s correlation coefficient</description>
  </primary_outcome>
  <primary_outcome>
    <measure>correlation between MAP and PDR for all and screening colonoscopies</measure>
    <time_frame>january 2013 - december 2017</time_frame>
    <description>Pearson´s correlation coefficient</description>
  </primary_outcome>
  <primary_outcome>
    <measure>correlation between ADR and PDR for all and screening colonoscopies</measure>
    <time_frame>january 2013 - december 2017</time_frame>
    <description>Pearson´s correlation coefficient</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">6925</enrollment>
  <condition>Colon Neoplasm</condition>
  <arm_group>
    <arm_group_label>Patients after colonoscopy over 50 years</arm_group_label>
    <description>All colonoscopies in patients over 50 years of age (screening, surveillance, diagnostic) excluding therapeutic, IBD, management of complications and sigmoidoscopies</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Colonoscopy</intervention_name>
    <description>Endoscopic examination of large bowel</description>
    <arm_group_label>Patients after colonoscopy over 50 years</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        people over 50 years of age coming for colonoscopic examination
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  people over 50 years of age coming for colonoscopic examination (screening,
             surveillance, diagnostic)

        Exclusion Criteria:

          -  age under 50 years

          -  indication for colonoscopy: therapeutic, IBD, management of complications and
             sigmoidoscopies
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ivana Mikoviny Kajzrlikova</last_name>
    <role>Principal Investigator</role>
    <affiliation>Doctor</affiliation>
  </overall_official>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>October 26, 2018</study_first_submitted>
  <study_first_submitted_qc>October 26, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 29, 2018</study_first_posted>
  <last_update_submitted>October 26, 2018</last_update_submitted>
  <last_update_submitted_qc>October 26, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 29, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Frydek-Mistek</investigator_affiliation>
    <investigator_full_name>Ivana Mikoviny Kajzrlikova, MD, PhD</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colonic Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>ADR, PDR, MAP of all endoscopists in our unit for both all and screening colonoscopies</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

